Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE: 300255)
China
· Delayed Price · Currency is CNY 20.31
+0.49 (2.47%)
Dec 27, 2024, 3:04 PM CST
Hebei Changshan Biochemical Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 314.22 | 230.92 | 797.8 | 543.21 | 481.02 | 563.31 | Upgrade
|
| Cash & Short-Term Investments | 314.22 | 230.92 | 797.8 | 543.21 | 481.02 | 563.31 | Upgrade
|
| Cash Growth | 1.01% | -71.05% | 46.87% | 12.93% | -14.61% | -44.81% | Upgrade
|
| Accounts Receivable | 280.4 | 238.08 | 452.99 | 317.09 | 427.22 | 355.89 | Upgrade
|
| Other Receivables | 18.81 | 80.43 | 43.03 | 39.24 | 43.75 | 27.85 | Upgrade
|
| Receivables | 299.21 | 318.52 | 496.02 | 356.33 | 470.97 | 383.75 | Upgrade
|
| Inventory | 1,448 | 1,644 | 2,431 | 2,285 | 1,887 | 1,408 | Upgrade
|
| Prepaid Expenses | - | - | 0.02 | 0.29 | 0.79 | 1.13 | Upgrade
|
| Other Current Assets | 179.03 | 82.14 | 172.24 | 223.68 | 159.64 | 178.09 | Upgrade
|
| Total Current Assets | 2,240 | 2,276 | 3,898 | 3,408 | 2,999 | 2,534 | Upgrade
|
| Property, Plant & Equipment | 1,674 | 1,591 | 1,483 | 1,193 | 1,064 | 935.32 | Upgrade
|
| Long-Term Investments | - | - | 1.46 | 5.8 | 18.18 | 6.2 | Upgrade
|
| Goodwill | - | - | 1.78 | 3.56 | 3.56 | 3.56 | Upgrade
|
| Other Intangible Assets | 312.52 | 320.55 | 263.82 | 274.06 | 251.6 | 173.17 | Upgrade
|
| Long-Term Deferred Tax Assets | 18.66 | 20.97 | 11.78 | 14 | 19.88 | 14.18 | Upgrade
|
| Long-Term Deferred Charges | 406.51 | 361.03 | 286.26 | 219.84 | 150.17 | 108.09 | Upgrade
|
| Other Long-Term Assets | 33.77 | 26.65 | 89.82 | 71.56 | 65.61 | 167.85 | Upgrade
|
| Total Assets | 4,686 | 4,596 | 6,036 | 5,190 | 4,573 | 3,943 | Upgrade
|
| Accounts Payable | 307.89 | 263.38 | 249.81 | 106.49 | 82.35 | 80.67 | Upgrade
|
| Accrued Expenses | 28.66 | 37.46 | 54.25 | 36.57 | 67.48 | 81.76 | Upgrade
|
| Short-Term Debt | 876.64 | 967.22 | 1,010 | 1,272 | 1,044 | 649.65 | Upgrade
|
| Current Portion of Long-Term Debt | - | 586.14 | 351.6 | 134.22 | 6.01 | 200 | Upgrade
|
| Current Portion of Leases | 698.64 | 0.39 | - | - | - | - | Upgrade
|
| Current Income Taxes Payable | 3.34 | 1.14 | 3.45 | 23.62 | 34.38 | 34.94 | Upgrade
|
| Current Unearned Revenue | 16.32 | 20.8 | 47.45 | 65.86 | 60.97 | - | Upgrade
|
| Other Current Liabilities | 42.93 | 44.4 | 71.65 | 95.31 | 117.04 | 141.11 | Upgrade
|
| Total Current Liabilities | 1,974 | 1,921 | 1,788 | 1,734 | 1,412 | 1,188 | Upgrade
|
| Long-Term Debt | 764.91 | 811.76 | 1,129 | 332.47 | 281.41 | - | Upgrade
|
| Long-Term Leases | 1.54 | 1.26 | - | - | - | - | Upgrade
|
| Long-Term Unearned Revenue | 46.37 | 62.48 | 64.8 | 51.02 | 25.37 | 30.79 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.32 | 0.35 | 0.19 | 0.2 | 0.48 | 0.81 | Upgrade
|
| Other Long-Term Liabilities | 126.78 | - | - | - | - | 0.6 | Upgrade
|
| Total Liabilities | 2,914 | 2,797 | 2,982 | 2,118 | 1,719 | 1,220 | Upgrade
|
| Common Stock | 919.06 | 919.06 | 934.97 | 934.97 | 934.97 | 934.97 | Upgrade
|
| Additional Paid-In Capital | 422.74 | 422.74 | 526.84 | 526.84 | 526.84 | 526.84 | Upgrade
|
| Retained Earnings | 477.28 | 469.99 | 1,794 | 1,800 | 1,567 | 1,326 | Upgrade
|
| Treasury Stock | - | - | -120.01 | -120.01 | -120.01 | - | Upgrade
|
| Comprehensive Income & Other | -0.13 | -0.13 | -77.86 | -73.5 | -61.13 | -73.11 | Upgrade
|
| Total Common Equity | 1,819 | 1,812 | 3,058 | 3,069 | 2,848 | 2,715 | Upgrade
|
| Minority Interest | -47.06 | -11.97 | -4.02 | 3.34 | 5.65 | 7.35 | Upgrade
|
| Shareholders' Equity | 1,772 | 1,800 | 3,054 | 3,072 | 2,853 | 2,722 | Upgrade
|
| Total Liabilities & Equity | 4,686 | 4,596 | 6,036 | 5,190 | 4,573 | 3,943 | Upgrade
|
| Total Debt | 2,342 | 2,367 | 2,490 | 1,739 | 1,331 | 849.65 | Upgrade
|
| Net Cash (Debt) | -2,028 | -2,136 | -1,692 | -1,195 | -850.24 | -286.34 | Upgrade
|
| Net Cash Per Share | -2.63 | -2.32 | -1.93 | -1.28 | -0.91 | -0.31 | Upgrade
|
| Filing Date Shares Outstanding | 919.06 | 919.06 | 919.06 | 919.06 | 919.06 | 934.97 | Upgrade
|
| Total Common Shares Outstanding | 919.06 | 919.06 | 919.06 | 919.06 | 919.06 | 934.97 | Upgrade
|
| Working Capital | 266.05 | 354.94 | 2,110 | 1,674 | 1,587 | 1,346 | Upgrade
|
| Book Value Per Share | 1.98 | 1.97 | 3.33 | 3.34 | 3.10 | 2.90 | Upgrade
|
| Tangible Book Value | 1,506 | 1,491 | 2,792 | 2,791 | 2,592 | 2,538 | Upgrade
|
| Tangible Book Value Per Share | 1.64 | 1.62 | 3.04 | 3.04 | 2.82 | 2.71 | Upgrade
|
| Buildings | - | 915.66 | 808.9 | 701.24 | 691.37 | 682.97 | Upgrade
|
| Machinery | - | 545.8 | 389.26 | 339.53 | 335.51 | 320.26 | Upgrade
|
| Construction In Progress | - | 547.74 | 642.27 | 462.72 | 311.26 | 162.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.